Overview

Chinese Medicine for Treating Chronic Pharyngolaryngitis

Status:
Not yet recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine formula in treating Chronic pharyngolaryngitis. Subjects will be randomized into a treatment group or placebo group for 8 weeks, and then followed by an 8-week post-treatment visit.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese University of Hong Kong